• Article

United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications

Citation

Hogue, S., Brogan, A., & Goodwin, B. (2013). United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications. Value in Health, 16(7), A364-A365.